Security key
034569103
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB)
CUSIP: 034569103
Q4 2022 13F Holders as of 31 Dec 2022
- Type / Class
- Equity / Common Stock
- Shares outstanding
- 41,587,315
- Total 13F shares
- 7,046,307
- Share change
- -6,254
- Total reported value
- $17,074,708
- Price per share
- $2.42
- Number of holders
- 12
- Value change
- -$15,992
- Number of buys
- 2
- Number of sells
- 4
Report period
Q4 2022
Institutions
12
Top holders
10
ANEB full security history
Newer quarter: Q1 2023
Previous quarter: Q3 2022
Anebulo Pharmaceuticals, Inc. SEC filings
Anebulo Pharmaceuticals, Inc. company facts
Broader feeds
Reporting periods
Holder history for CUSIP 034569103
Recent filing periods:
Top shareholders of ANEB - Anebulo Pharmaceuticals, Inc. - Common Stock (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked first by SEC-reported ownership % when it is safely comparable, then by disclosed holdings value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| 22NW, LP |
13F
|
Company |
12%
|
5,066,290
|
$14,186,000 | — | 30 Sep 2022 | |
| LVW Advisors, LLC |
13F
|
Company |
1.6%
|
674,964
|
$1,890,000 | — | 30 Sep 2022 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
1.2%
|
511,073
|
$1,431,000 | — | 30 Sep 2022 | |
| MANGROVE PARTNERS IM, LLC |
13F
|
Company |
0.96%
|
399,219
|
$1,118,000 | — | 30 Sep 2022 | |
| Ikarian Capital, LLC |
13F
|
Company |
0.38%
|
156,203
|
$437,000 | — | 30 Sep 2022 | |
| BOOTHBAY FUND MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
17,319
|
$48,000 | — | 30 Sep 2022 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
7,330
|
$21,000 | — | 30 Sep 2022 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.02%
|
7,133
|
$20,000 | — | 30 Sep 2022 | |
| UBS Group AG |
13F
|
Company |
0.01%
|
2,781
|
$8,000 | — | 30 Sep 2022 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
600
|
$2,000 | — | 30 Sep 2022 | |
| Simon Allen |
3/4/5
|
Chief Executive Officer, Director |
—
class O/S missing
|
70,246
|
— | — | 09 Dec 2022 | |
| Karah Herdman Parschauer |
3/4/5
|
Director |
—
class O/S missing
|
30,425
|
— | — | 21 Apr 2022 |
Institutional Holders of Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) as of Q4 2022
As of 31 Dec 2022,
Anebulo Pharmaceuticals, Inc. - Common Stock (ANEB) was held by
12 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
7,046,307 shares.
The largest 10 holders included
22NW, LP, LVW Advisors, LLC, Nantahala Capital Management, LLC, MANGROVE PARTNERS, Praetorian Capital Management LLC, Ikarian Capital, LLC, Herr Investment Group LLC, BOOTHBAY FUND MANAGEMENT, LLC, BlackRock Inc., and Tower Research Capital LLC (TRC).
This page lists
12
institutional shareholders reporting positions in this security
for the Q4 2022 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q4 2022 vs Q3 2022 Across Filers
Q3 2022 holders
10
Q4 2022 holders
12
Holder diff
2
| Investor | Q3 2022 Shares | Q4 2022 Shares | Share Diff | Share Chg % | Q3 2022 Value $ | Q4 2022 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.